Since IL-1R8 can negatively modulate the expression of inflammatory mediators in IL-1R-stimulated transformed breast epithelial cells in vitro, we sought to analyze its role on the immune composition in vivo using our transgenic mouse model of breast cancer. Here, SIGIRR is linked to breast carcinoma.